Regenxbio Inc (RGNX)
Debt-to-equity ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 311,742 | 516,195 | 764,298 | 377,753 | 450,197 |
Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $311,742K
= 0.00
Based on the data provided from 2019 to 2023, Regenxbio Inc maintains a debt-to-equity ratio of 0.00 for each year. A debt-to-equity ratio of 0.00 indicates that the company has no debt relative to its equity. This signifies that the company is primarily funded by equity rather than debt financing.
Having a consistent debt-to-equity ratio of 0.00 over the years suggests that Regenxbio Inc has been cautious in managing its debt levels and has not relied heavily on borrowing to finance its operations or growth.
While a low or zero debt-to-equity ratio can indicate a conservative financial structure and lower financial risk, it's essential to consider that excessive reliance on equity financing may limit the company's growth opportunities or profitability potential compared to leveraging debt for strategic investments.
In summary, Regenxbio Inc's consistent debt-to-equity ratio of 0.00 reflects a conservative financial strategy with little to no debt exposure, potentially providing a stable financial base for the company's operations and growth initiatives.
Peer comparison
Dec 31, 2023